Jazz PharmaceuticalsvsJohnson & Johnson

JAZZ and JNJ stock compared: price, dividend, valuation and results, from SEC filings.

JAZZ

Jazz Pharmaceuticals plc

$247.77

Value $15.5B

+2.93%
JAZZ's page

Jazz Pharmaceuticals (JAZZ) has a market value of $15.5B and Johnson & Johnson (JNJ) $657B. Over the last year, with dividends, JAZZ moved +45.7% and JNJ +39.7%. The P/E is 75.5 for JAZZ and 40.8 for JNJ. Dividend yield: JAZZ none, JNJ 1.94%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    JAZZ$15.5B

    JNJ$657B

    JNJ is 42 times JAZZ

  • Revenue, 12 months

    JAZZ$4.7B

    JNJ$99.3B

    JNJ is 21 times JAZZ

  • Net income, 12 months

    JAZZ$206M

    JNJ$16.1B

    JNJ is 78 times JAZZ

  • Operating margin

    JAZZ9.0%

    JNJ–

  • ROIC

    JAZZ3.5%

    JNJ12.4%

    8.9 points apart

  • P/E

    JAZZ75.5

    JNJ40.8

    JAZZ is 1.8 times JNJ

  • Dividend yield

    JAZZ0.0%

    JNJ1.9%

    1.9 points apart

  • 5-year return

    JAZZ+86.2%

    JNJ+92.0%

    5.8 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

JAZZ+86.2%

JNJ+92.0%

10015020020222023202420252026
Returns by period
PeriodJAZZWith dividendsJNJWith dividends
1 year since November 17, 2025+45.7%Price +45.7%+39.7%Price +36.6%
3 years since November 17, 2023+105.5%+27.1% a yearPrice +105.5%+98.2%+25.6% a yearPrice +82.1%
5 years since November 17, 2021+86.2%+13.2% a yearPrice +86.2%+92.0%+13.9% a yearPrice +67.0%
10 years since November 18, 2016+126.8%+8.5% a yearPrice +126.8%+208.0%+11.9% a yearPrice +136.4%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

JAZZJazz PharmaceuticalsJNJJohnson & Johnson

Valuation

JAZZJNJ
Valuation
Price$247.77$272.70
Market value$15.5B$657B
Enterprise value (EV)$18.3B$685B
P/E75.540.8
P/E, 5-year median–21.9
P/B3.78.1
EV/EBIT42.938.6
Free cash flow yield10.4%3.1%

Results and growth

JAZZJNJ
Results and growth
Revenue, 12 months$4.7B$99.3B
Net income, 12 months$206M$16.1B
Free cash flow, 12 months$1.6B$20.6B
Earnings per share, 12 months$3.07$6.59
Revenue growth, year on year4.9%6.1%
Revenue growth a year, past+12.5%over 5 years+2.7%over 5 years
EPS growth a year, past–+14.9%over 5 years

Margins and returns on capital

JAZZJNJ
Margins and returns on capital
Gross margin–67.6%
Operating margin9.0%–
Net margin4.4%16.2%
ROIC3.5%12.4%
ROE4.7%19.7%

Balance sheet

JAZZJNJ
Balance sheet
Cash$2.9B$17.2B
Total debt$5.6B$44.7B
Net debt / EBITDA5.81.1
Interest cover–18.0×

Dividends and buybacks

JAZZJNJ
Dividends and buybacks
Dividend yield–1.9%
Dividend per share, 12 months–$5.28
Dividend growth a year, past–+5.3%over 5 years
Buyback yield0.8%0.9%
Shareholder yield0.8%2.9%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: JAZZ or JNJ

Didn't find what you were looking for?

Ask us
Which is bigger, Jazz Pharmaceuticals or Johnson & Johnson?

By market value, Johnson & Johnson ($657B) is about 42.3 times Jazz Pharmaceuticals ($15.5B), at today's prices.

How did JAZZ and JNJ stock do over the last 10 years?

Since November 18, 2016, JAZZ's price moved +126.8% and JNJ's +136.4%. With dividends: JAZZ +126.8% (+8.5% a year), JNJ +208.0% (+11.9% a year). Past returns do not predict future ones.

Which pays the higher dividend, JAZZ or JNJ?

The dividend yield at today's price is none for Jazz Pharmaceuticals and 1.94% for Johnson & Johnson. Over the last twelve months they paid – and $5.28 per share.

What is the P/E of JAZZ and JNJ?

At today's price, the P/E is 75.5 for JAZZ and 40.8 for JNJ. It is the share price over the last twelve months' earnings per share.

Which has the higher profit margins, Jazz Pharmaceuticals or Johnson & Johnson?

Over the last twelve months, the net margin was 4.4% for Jazz Pharmaceuticals and 16.2% for Johnson & Johnson, and the operating margin 9.0% and –. Revenue was $4.7B and $99.3B.

Which is the better investment, Jazz Pharmaceuticals or Johnson & Johnson?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.